CHEYENNE MENGERS: Open Payments
NPI 1780243667 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 59 payments from 19 companies in 2025. Trend: 2023 $785 · 2024 $2,043 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $330 |
| Lilly USA, LLC | 9 | $174 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Inspire Medical Systems, Inc. | 1 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
Products named: Ozempic, TRELEGY ELLIPTA, INSPIRE, JARDIANCE, TRINTELLIX, Rybelsus, CAPLYTA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
